Skip to content

GRFS

Grifols SA

NASDAQ · Healthcare · Drug Manufacturers - General · ES

$7.31
−1.22%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 10, 2026
EPS estimate
$0.30
Revenue estimate
$2.3B

Latest reported

Last report date
Jul 28, 2026
EPS actual
$0.25
EPS estimate
$0.27
Revenue actual
$2.1B
Revenue estimate
$2.2B

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
10
EPS in line (12Q)
0
Avg surprise (4Q)
+22.7%
Revenue beats (12Q)
3
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jul 28, 2026$0.27$0.25Miss -6.96%$2.1B
May 7, 2026$0.16$0.17Beat 7.32%$2.0B
Nov 4, 2025$0.24$0.22Miss -9.60%$2.2B
Mar 6, 2025$0.13$0.26Beat 100.00%$2.0B
Nov 7, 2024$0.22$0.16Miss -27.27%$2.0B
May 14, 2024$0.15$0.07Miss -53.33%$1.8B
Mar 5, 2024$0.22$0.14Miss -36.36%$1.9B
Nov 2, 2023$0.22$0.11Miss -50.00%$1.7B
Jul 27, 2023$0.20$0.09Miss -54.80%$1.8B
May 15, 2023$0.16-$0.02Miss -110.67%$1.7B
Mar 13, 2023$0.24$0.03Miss -86.72%$1.8B
Jul 28, 2022$0.29$0.14Miss -52.25%$1.6B

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026